Huadong Medicine Co., Ltd. (000963.SZ): Registration Application for Lidocaine Injection Cross-Linked Sodium Hyaluronate Gel Accepted

Stock News10-16

Zhito Finance APP reported that Huadong Medicine Co., Ltd. (000963.SZ) announced that its wholly-owned subsidiary Xinke Liyuan Aesthetics (Hangzhou) Medical Technology Co., Ltd. has received an "Acceptance Notice" issued by the National Medical Products Administration (NMPA) for its registration application of a Class III medical device, the MaiLi Precise Lidocaine Injection Cross-Linked Sodium Hyaluronate Gel.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment